Literature DB >> 1932304

Detection of engraftment and mixed chimerism following bone marrow transplantation using PCR amplification of a highly variable region-variable number of tandem repeats (VNTR) in the von Willebrand factor gene.

A Gaiger1, C Mannhalter, W Hinterberger, O Haas, C Marosi, P Kier, S Eichinger, M Funovic, K Lechner.   

Abstract

Detection of host cells in peripheral blood and/or bone marrow (mixed chimerism) of patients who have undergone bone marrow transplantation (BMT) is possible using either immunological methods or cytogenetic or molecular genetic analysis. We shall report a new method for the detection of mixed chimerism, which makes use of the fact, that the von Willebrand factor (vWF) gene has a highly variable region-variable number of tandem repeats (VNTR)--within intron 40. vWF-VNTR amplification by the polymerase chain reaction (PCR) was performed as described by Peake et al. We have studied 185 peripheral blood and/or bone marrow samples of 26 patients. Median time after BMT was 14 months (range 1-83 months). Of the 11 patients who were studied sequentially during the first 100 days following BMT, mixed chimerism was detected in four, but only transiently. None of these patients has relapsed so far. Of 18 patients who were studied more than 100 days after BMT mixed chimerism was found in three; two of these patients have subsequently relapsed. The advantages of this new method are: (a) it is informative in a high percentage of patients; (b) it requires only small amounts (200 microliters) of peripheral blood; (c) reliable results can be obtained at leukocyte counts of even less than 50 per microliters. The clinical relevance and sensitivity of the method compared with established methods for detection of mixed chimerism remain to be determined.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1932304     DOI: 10.1007/bf01703449

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  5 in total

1.  Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation.

Authors:  K Offit; J P Burns; I Cunningham; S C Jhanwar; P Black; N A Kernan; R J O'Reilly; R S Chaganti
Journal:  Blood       Date:  1990-03-15       Impact factor: 22.113

2.  Cytogenetic studies in bone marrow transplant recipients.

Authors:  O A Haas; W Hinterberger; W Schmidmeier; C Pollak; M Hinterberger; H Gadner; K Lechner
Journal:  Blut       Date:  1986-07

3.  Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay.

Authors:  D M Durnam; K R Anders; L Fisher; J O'Quigley; E M Bryant; E D Thomas
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

4.  Origin of leukemic relapse after bone marrow transplantation: comparison of cytogenetic and molecular analyses.

Authors:  J Stein; P A Zimmerman; M Kochera; S Strandjord; W Golden; M Simon; P Warkentin; B R Blazar; P Coccia; N Lang-Unnasch
Journal:  Blood       Date:  1989-05-15       Impact factor: 22.113

5.  Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene.

Authors:  I R Peake; D Bowen; P Bignell; M B Liddell; J E Sadler; G Standen; A L Bloom
Journal:  Blood       Date:  1990-08-01       Impact factor: 22.113

  5 in total
  2 in total

1.  Validation of chimerism in pediatric recipients of allogeneic hematopoietic stem cell transplantation (HSCT) a comparison between two methods: real-time PCR (qPCR) vs. variable number tandem repeats PCR (VNTR PCR).

Authors:  Morris Kletzel; Wei Huang; Marie Olszewski; Sana Khan
Journal:  Chimerism       Date:  2012-12-13

2.  Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.

Authors:  H T Greinix; F Keil; S A Brugger; E Reiter; W Linkesch; K Lechner; B Schneider; K U Dieckmann; G Fischer; I Schwarzinger; O Haas; W Hinterberger; C Mannhalter; K Geissler; P Hocker; U Jager; P Kalhs
Journal:  Ann Hematol       Date:  1996-02       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.